Encouraging and rewarding novel and innovative solutions to the unmet needs of the worldwide rare disease communities.

The PTC Therapeutics grant awards program Strategies to Realize Innovation, Vision and Empowerment (STRIVE) is designed to aid nonprofit organizations that are committed to serving rare disease communities. The STRIVE Program recognizes the vital role patient advocacy groups play in giving voice to individuals affected by these rare diseases. Specifically, PTC seeks to facilitate unique, inventive ideas, methods or programs that support patients and families within rare disease communities.

Funds are awarded to qualifying organizations via a competitive process in which all entries are reviewed by an independent, external committee. The judges have pertinent experience in rare diseases, patient advocacy and funding initiatives. The awards are for one year.

Applications for the 2019 STRIVE for Duchenne muscular dystrophy awards are now available.

By selecting Confirm, you are leaving the PTC Therapeutics U.S. website. This external link is provided for your convenience. Please note that external links or web sites may not be controlled by PTC Therapeutics, and thus not subject to our Privacy policy and Terms of use.

Thank you for visiting our site.
Cancel Confirm
This site uses cookies to store information on your computer.
Cancel Continue